311 related articles for article (PubMed ID: 22243420)
1. Concomitant use of clopidogrel and statins and risk of major adverse cardiovascular events following coronary stent implantation.
Schmidt M; Johansen MB; Maeng M; Kaltoft A; Jensen LO; Tilsted HH; Bøtker HE; Baron JA; Sørensen HT
Br J Clin Pharmacol; 2012 Jul; 74(1):161-70. PubMed ID: 22243420
[TBL] [Abstract][Full Text] [Related]
2. Concomitant use of clopidogrel and proton pump inhibitors is not associated with major adverse cardiovascular events following coronary stent implantation.
Schmidt M; Johansen MB; Robertson DJ; Maeng M; Kaltoft A; Jensen LO; Tilsted HH; Bøtker HE; Sørensen HT; Baron JA
Aliment Pharmacol Ther; 2012 Jan; 35(1):165-74. PubMed ID: 22050009
[TBL] [Abstract][Full Text] [Related]
3. Use of clopidogrel and calcium channel blockers and risk of major adverse cardiovascular events.
Schmidt M; Johansen MB; Robertson DJ; Maeng M; Kaltoft A; Jensen LO; Tilsted HH; Bøtker HE; Sørensen HT; Baron JA
Eur J Clin Invest; 2012 Mar; 42(3):266-74. PubMed ID: 21834799
[TBL] [Abstract][Full Text] [Related]
4. Lack of adverse clopidogrel-atorvastatin clinical interaction from secondary analysis of a randomized, placebo-controlled clopidogrel trial.
Saw J; Steinhubl SR; Berger PB; Kereiakes DJ; Serebruany VL; Brennan D; Topol EJ;
Circulation; 2003 Aug; 108(8):921-4. PubMed ID: 12925453
[TBL] [Abstract][Full Text] [Related]
5. Lack of evidence of a clopidogrel-statin interaction in the CHARISMA trial.
Saw J; Brennan DM; Steinhubl SR; Bhatt DL; Mak KH; Fox K; Topol EJ;
J Am Coll Cardiol; 2007 Jul; 50(4):291-5. PubMed ID: 17659194
[TBL] [Abstract][Full Text] [Related]
6. Lack of clopidogrel-CYP3A4 statin interaction in patients with acute coronary syndrome.
Mukherjee D; Kline-Rogers E; Fang J; Munir K; Eagle KA
Heart; 2005 Jan; 91(1):23-6. PubMed ID: 15604326
[TBL] [Abstract][Full Text] [Related]
7. Investigation of an interaction between statins and clopidogrel after percutaneous coronary intervention: a cohort study.
Blagojevic A; Delaney JA; Lévesque LE; Dendukuri N; Boivin JF; Brophy JM
Pharmacoepidemiol Drug Saf; 2009 May; 18(5):362-9. PubMed ID: 19253920
[TBL] [Abstract][Full Text] [Related]
8. Routine assessment of on-clopidogrel platelet reactivity and gene polymorphisms in predicting clinical outcome following drug-eluting stent implantation in patients with stable coronary artery disease.
Viviani Anselmi C; Briguori C; Roncarati R; Papa L; Visconti G; Focaccio A; De Micco F; Latronico MV; Pagnotta P; Condorelli G
JACC Cardiovasc Interv; 2013 Nov; 6(11):1166-75. PubMed ID: 24262617
[TBL] [Abstract][Full Text] [Related]
9. Study design and rationale of 'Influence of Cilostazol-based triple anti-platelet therapy on ischemic complication after drug-eluting stent implantation (CILON-T)' study: A multicenter randomized trial evaluating the efficacy of Cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease.
Lee SP; Suh JW; Park KW; Lee HY; Kang HJ; Koo BK; Chae IH; Choi DJ; Rha SW; Bae JW; Cho MC; Kwon TG; Bae JH; Kim HS;
Trials; 2010 Aug; 11():87. PubMed ID: 20735821
[TBL] [Abstract][Full Text] [Related]
10. Concomitant administration of clopidogrel with statins or calcium-channel blockers: insights from the TRITON-TIMI 38 (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38).
Ojeifo O; Wiviott SD; Antman EM; Murphy SA; Udell JA; Bates ER; Mega JL; Sabatine MS; O'Donoghue ML
JACC Cardiovasc Interv; 2013 Dec; 6(12):1275-81. PubMed ID: 24239201
[TBL] [Abstract][Full Text] [Related]
11. Statins do not adversely affect post-interventional residual platelet aggregation and outcomes in patients undergoing coronary stenting treated by dual antiplatelet therapy.
Geisler T; Zürn C; Paterok M; Göhring-Frischholz K; Bigalke B; Stellos K; Seizer P; Kraemer BF; Dippon J; May AE; Herdeg C; Gawaz M
Eur Heart J; 2008 Jul; 29(13):1635-43. PubMed ID: 18503057
[TBL] [Abstract][Full Text] [Related]
12. Myonecrosis after elective percutaneous coronary intervention: effect of clopidogrel-statin interaction.
Gulec S; Ozdol C; Rahimov U; Atmaca Y; Kumbasar D; Erol C
J Invasive Cardiol; 2005 Nov; 17(11):589-93. PubMed ID: 16264203
[TBL] [Abstract][Full Text] [Related]
13. Statin Discontinuation and Cardiovascular Events Among Older People in Denmark.
Thompson W; Morin L; Jarbøl DE; Andersen JH; Ernst MT; Nielsen JB; Haastrup P; Schmidt M; Pottegård A
JAMA Netw Open; 2021 Dec; 4(12):e2136802. PubMed ID: 34854906
[TBL] [Abstract][Full Text] [Related]
14. Clopidogrel discontinuation within the first year after coronary drug-eluting stent implantation: an observational study.
Thim T; Johansen MB; Chisholm GE; Schmidt M; Kaltoft A; Sørensen HT; Thuesen L; Kristensen SD; Bøtker HE; Krusell LR; Lassen JF; Thayssen P; Jensen LO; Tilsted HH; Maeng M
BMC Cardiovasc Disord; 2014 Aug; 14():100. PubMed ID: 25125079
[TBL] [Abstract][Full Text] [Related]
15. [Influence of statins on the antiplatelet effect of clopidogrel and on cardiovascular outcome in patients after coronary intervention].
Zürn CS; Geisler T; Paterok M; Gawaz M
Dtsch Med Wochenschr; 2008 Apr; 133(16):817-22. PubMed ID: 18398789
[TBL] [Abstract][Full Text] [Related]
16. Exploring the ticagrelor-statin interplay in the PLATO trial.
Dinicolantonio JJ; Serebruany VL
Cardiology; 2013; 124(2):105-7. PubMed ID: 23407140
[TBL] [Abstract][Full Text] [Related]
17. Impact of cytochrome P450 3A4-metabolized statins on the antiplatelet effect of a 600-mg loading dose clopidogrel and on clinical outcome in patients undergoing elective coronary stent placement.
Trenk D; Hochholzer W; Frundi D; Stratz C; Valina CM; Bestehorn HP; Büttner HJ; Neumann FJ
Thromb Haemost; 2008 Jan; 99(1):174-81. PubMed ID: 18217151
[TBL] [Abstract][Full Text] [Related]
18. Nonsteroidal antiinflammatory drug use and cardiovascular risks after coronary stent implantation.
Schmidt M; Pedersen L; Maeng M; Lassen JF; Lash TL; Nielsen TT; Sørensen HT
Pharmacotherapy; 2011 May; 31(5):458-68. PubMed ID: 21923427
[TBL] [Abstract][Full Text] [Related]
19. Accelerated platelet inhibition by switching from atorvastatin to a non-CYP3A4-metabolized statin in patients with high platelet reactivity (ACCEL-STATIN) study.
Park Y; Jeong YH; Tantry US; Ahn JH; Kwon TJ; Park JR; Hwang SJ; Gho EH; Bliden KP; Kwak CH; Hwang JY; Kim S; Gurbel PA
Eur Heart J; 2012 Sep; 33(17):2151-62. PubMed ID: 22507978
[TBL] [Abstract][Full Text] [Related]
20. A pharmacoepidemiology study of the interaction between atorvastatin and clopidogrel after percutaneous coronary intervention.
Brophy JM; Babapulle MN; Costa V; Rinfret S
Am Heart J; 2006 Aug; 152(2):263-9. PubMed ID: 16875906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
